Abstract P340: 30-Day Readmission Risk Assessment Among Patients Who Underwent Transcatheter Aortic Valve Replacement (TAVR), ACS NSQIP, 2015-2017

Publication Date

2020

Presented At:

American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2020 Scientific Sessions

Content Type

Presentation

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors & institutional affiliations

This document is currently not available here.

Share

COinS